Although serial echocardiography (ECHO) is recommended every three months during treatment with trastuzumab for cardiotoxicity screening, this recommendation is based on expert opinion. We sought to investigate the incidence of… Click to show full abstract
Although serial echocardiography (ECHO) is recommended every three months during treatment with trastuzumab for cardiotoxicity screening, this recommendation is based on expert opinion. We sought to investigate the incidence of Trastuzumab cardiotoxicity in real-world patients, its potential impact
               
Click one of the above tabs to view related content.